Summary:
Double-Blind, Placebo-Controlled, Phase 2 Trial to Test Efficacy and Safety of AV-101 (L-4-chlorokynurenine) as Adjunct to Current Antidepressant Therapy in Patients with Major Depressive Disorder (MDD) with an Inadequate Response to Current Antidepressants (the ELEVATE study)
Qualified Participants Must:
• Male or female, 18 to 65 years of age
Qualified Participants May Receive:
Compensation for time and travel